Legend Biotech price target lowered to $80 from $82 at Morgan Stanley
Morgan Stanley analyst Vikram Purohit lowered the firm’s price target on Legend Biotech (LEGN) to $80 from $82 and keeps an Overweight rating ...
Legend Biotech Co. (NASDAQ:LEGN) Receives $79.00 Average PT from Analysts
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. One ...